Furthermore, inhibition of the VILIP3/NFκB/Bcl-2 regulatory axis was also observed in the desloratadine-treated Huh7 and HepG2 tumor xenografts (Supplementary Fig. 7). Here, BCL2 is linked to neoplasm.